Onasemnogene abeparvovec
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Onasemnogene abeparvovec, covering 2025-07-09 to 2025-07-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec [Phase 1]